Biotherapy in the Adjuvant Treatment of Colorectal Cancer.

Gastroenterology Res · 2011 · PMC5139728 · PMID 27942334

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

With longer follow-up, the DFS advantage in favor of the addition of oxaliplatin remained, and a favorable trend appears to be emerging for OS.

also in 1,053 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.